Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2FED 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 15Breast 12Other 8Genitourinary 6Lymphoid 5Other hematologic neoplasm 4Gynecologic 3Endocrine 3Tumor-Agnostic 2Thoracic 2Myeloid 1Head & Neck 1Dermatologic 1CNS 1

Conditions

Lung Neoplasms 2Weight Loss 1Urologic Neoplasms 1Smoking Cessation 1Prostatic Neoplasms 1Neoplasms 1Gastrointestinal Neoplasms 1

Interventions

Carboplatin 510Cisplatin 410Pemetrexed 400Radiotherapy 285Docetaxel 244Paclitaxel 227pembrolizumab 226Gemcitabine 198Drug Therapy 191Bevacizumab 190Erlotinib Hydrochloride 189Radiosurgery 177Nivolumab 168Etoposide 155durvalumab 154osimertinib 126atezolizumab 109Gefitinib 96Blood Specimen Collection 93Magnetic Resonance Spectroscopy 91Vinorelbine 90anlotinib 88Surgical Procedures, Operative 85Ipilimumab 62Immunotherapy 62Surveys and Questionnaires 60sintilimab 59Specimen Handling 59tislelizumab 58Irinotecan 57

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Diet × Thoracic × Clear all
NCT03785808 2019-08-12

RIGHT

Fred Hutchinson Cancer Center

Phase NA Terminated
3 enrolled
Thoracic

Lung Neoplasms

NCT03410641 2018-01-25

Long-term Cancer Risk in the Randomised Oslo Diet and Antismoking Study

Oslo University Hospital

Completed
1,216 enrolled
GastrointestinalGenitourinaryThoracic

Gastrointestinal Neoplasms, Lung Neoplasms, Neoplasms, Prostatic Neoplasms, Urologic Neoplasms, Weight Loss, Smoking Cessation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡